# Assessing the Efficacy of Steroid Treatment of Achalasia

> **NCT01903486** · PHASE4 · WITHDRAWN · sponsor: **Mayo Clinic**

## Conditions studied

- Achalasia

## Interventions

- **DRUG:** Apo-Prednisone Cordorol, Detasone - Prednisone

## Key facts

- **NCT ID:** NCT01903486
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-03
- **Primary completion:** 2020-12-28
- **Final completion:** 2020-12-28
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to recruit participants.
- **Last updated:** 2021-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01903486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01903486, "Assessing the Efficacy of Steroid Treatment of Achalasia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01903486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*